Insmed (INSM)
104.92
0.00 (0.00%)
Upcoming Events
Latest Headlines
Insmed (INSM) PT Lowered to $195 at RBC Capital
June 5, 2026 5:42 AM - StreetInsider
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
June 4, 2026 7:00 AM - PR NewsWire
Form 144 INSMED Inc Filed by: Bonstein Sara
June 3, 2026 4:41 PM - SEC Filing
Form 144 INSMED Inc Filed by: Flammer Martina M.D.
June 3, 2026 4:36 PM - SEC Filing
Form 144 INSMED Inc Filed by: Adsett Roger
June 3, 2026 4:29 PM - SEC Filing
Form 144 INSMED Inc Filed by: Smith Michael Alexander
June 3, 2026 4:22 PM - SEC Filing
Form 144 INSMED Inc Filed by: Lewis William
June 3, 2026 4:10 PM - SEC Filing
JPMorgan says large-cap biotech is back as profits and pipelines fuel upside
May 28, 2026 4:07 PM - StreetInsider
Insmed to Present at the 2026 Goldman Sachs Annual Global Healthcare Conference
May 27, 2026 7:00 AM - PR NewsWire
Form 144 INSMED Inc Filed by: Smith Michael Alexander
May 22, 2026 4:55 PM - SEC Filing
Form 4 INSMED Inc For: May 22 Filed by: Smith Michael Alexander
May 22, 2026 4:25 PM - SEC Filing
Form 4 INSMED Inc For: May 18 Filed by: Lewis William
May 20, 2026 4:07 PM - SEC Filing
JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms
May 20, 2026 3:10 PM - StreetInsider
JPMorgan Reinstates Insmed (INSM) at Overweight
May 20, 2026 4:30 AM - StreetInsider
Form 144 INSMED Inc Filed by: Lewis William
May 18, 2026 4:54 PM - SEC Filing
Form S-3ASR INSMED Inc
May 15, 2026 5:06 PM - SEC Filing
Form SCHEDULE 13G/A INSMED Inc Filed by: Darwin Global Management, Ltd.
May 15, 2026 5:04 PM - SEC Filing
Form 4 INSMED Inc For: May 13 Filed by: Bonstein Sara
May 15, 2026 4:13 PM - SEC Filing
Form 4 INSMED Inc For: May 13 Filed by: SCHAFER CAROL
May 15, 2026 4:13 PM - SEC Filing
Form 4 INSMED Inc For: May 13 Filed by: Adsett Roger
May 15, 2026 4:13 PM - SEC Filing
Form 4 INSMED Inc For: May 13 Filed by: ANDERSON ELIZABETH M
May 15, 2026 4:13 PM - SEC Filing
Form 4 INSMED Inc For: May 13 Filed by: Flammer Martina M.D.
May 15, 2026 4:12 PM - SEC Filing
Form 4 INSMED Inc For: May 13 Filed by: Smith Michael Alexander
May 15, 2026 4:12 PM - SEC Filing
Form 4 INSMED Inc For: May 13 Filed by: SHAROKY MELVIN MD
May 15, 2026 4:12 PM - SEC Filing
Form 4 INSMED Inc For: May 13 Filed by: Brennan David R
May 15, 2026 4:12 PM - SEC Filing
Form 4 INSMED Inc For: May 13 Filed by: LEE LEO
May 15, 2026 4:12 PM - SEC Filing
Form 4 INSMED Inc For: May 13 Filed by: Desjardins Clarissa
May 15, 2026 4:12 PM - SEC Filing
Form 4 INSMED Inc For: May 13 Filed by: Lewis William
May 15, 2026 4:12 PM - SEC Filing
Form 8-K INSMED Inc For: May 13
May 15, 2026 4:03 PM - SEC Filing
Insmed (INSM) PT Lowered to $162 at Evercore ISI
May 15, 2026 6:13 AM - StreetInsider
Form 144 INSMED Inc Filed by: Flammer Martina M.D.
May 14, 2026 5:20 PM - SEC Filing
Form 144 INSMED Inc Filed by: Adsett Roger
May 13, 2026 5:25 PM - SEC Filing
Form 144 INSMED Inc Filed by: Smith Michael Alexander
May 13, 2026 5:19 PM - SEC Filing
Form 144 INSMED Inc Filed by: Bonstein Sara
May 13, 2026 5:18 PM - SEC Filing
Form 144 INSMED Inc Filed by: Flammer Martina M.D.
May 13, 2026 5:17 PM - SEC Filing
Form 144 INSMED Inc Filed by: Lewis William
May 13, 2026 5:14 PM - SEC Filing
Form 4 INSMED Inc For: May 11 Filed by: Flammer Martina M.D.
May 13, 2026 4:50 PM - SEC Filing
Insmed (INSM) PT Lowered to $185 at Truist Securities
May 13, 2026 1:06 PM - StreetInsider
BofA Securities Reiterates Buy Rating on Insmed (INSM); 'pullback overdone'
May 12, 2026 12:02 PM - StreetInsider
Form 144 INSMED Inc Filed by: Flammer Martina M.D.
May 11, 2026 4:47 PM - SEC Filing
Buy the dip in this stock after a 23% earnings drop: Wall Street
May 8, 2026 11:00 AM - StreetInsider
Insmed (INSM) PT Lowered to $205 at RBC Capital
May 8, 2026 7:32 AM - StreetInsider
Insmed (INSM) PT Raised to $226 at Guggenheim
May 8, 2026 7:22 AM - StreetInsider
Insmed (INSM) PT Lowered to $160 at Wells Fargo
May 8, 2026 6:57 AM - StreetInsider
Insmed (INSM) Tops Q1 EPS by 20c
May 7, 2026 7:39 AM - StreetInsider
Form 8-K INSMED Inc For: May 07
May 7, 2026 7:02 AM - SEC Filing
Form 10-Q INSMED Inc For: Mar 31
May 7, 2026 7:01 AM - SEC Filing
Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update
May 7, 2026 7:00 AM - PR NewsWire
Insmed and Ty Pennington Team Up to Drive Awareness and Proper Diagnosis of Bronchiectasis
May 6, 2026 4:30 PM - PR NewsWire
Form 4 INSMED Inc For: May 04 Filed by: Lewis William
May 6, 2026 4:12 PM - SEC Filing
Form SCHEDULE 13G INSMED Inc Filed by: FMR LLC
May 6, 2026 11:24 AM - SEC Filing
Form 144 INSMED Inc Filed by: Lewis William
May 4, 2026 4:55 PM - SEC Filing
Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026
May 4, 2026 7:00 AM - PR NewsWire
Form SCHEDULE 13G INSMED Inc Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 30, 2026 10:38 AM - SEC Filing
Insmed to Present at May 2026 Investor Conferences
April 30, 2026 7:00 AM - PR NewsWire
Insmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026
April 23, 2026 7:01 AM - PR NewsWire
Form 4 INSMED Inc For: Apr 16 Filed by: Lewis William
April 17, 2026 4:44 PM - SEC Filing
Form 144 INSMED Inc Filed by: Lewis William
April 16, 2026 4:17 PM - SEC Filing
Insmed (INSM) PT Raised to $230 at Guggenheim
April 16, 2026 7:14 AM - StreetInsider
Insmed (INSM) PT Raised to $216 at RBC Capital
April 14, 2026 6:33 AM - StreetInsider
Raymond James Starts Insmed (INSM) at Outperform, 'Brinsupri Launch at Peak Performance, With Room to Breathe'
April 9, 2026 4:26 PM - StreetInsider
Form 4 INSMED Inc For: Apr 06 Filed by: Lewis William
April 8, 2026 4:42 PM - SEC Filing
Insmed (INSM) PT Lowered to $212 at BofA Securities
April 8, 2026 9:22 AM - StreetInsider
Insmed (INSM) Reiterated at Buy by Stifel Amid Returning Focus on Brinsupri Sales
April 8, 2026 7:13 AM - StreetInsider
Insmed (INSM) PT Lowered to $220 at H.C. Wainwright
April 8, 2026 7:11 AM - StreetInsider
Insmed (INSM) PT Lowered to $202 at Mizuho
April 8, 2026 6:38 AM - StreetInsider
Truist Securities on Insmed (INSM): brensocatib in HS failure unsuprising, 'stock doesn't reflect any meaningful value for HS'
April 7, 2026 4:55 PM - StreetInsider
After-hours movers: Levi, Greenbrier, Aehr Test and more
April 7, 2026 4:36 PM - StreetInsider
Form 8-K INSMED Inc For: Apr 07
April 7, 2026 4:02 PM - SEC Filing
Insmed discontinues hidradenitis suppurativa program after failed trial
April 7, 2026 4:01 PM - StreetInsider
Insmed Provides Clinical Update on Phase 2b CEDAR Study
April 7, 2026 4:01 PM - PR NewsWire
Insmed (INSM) halted, news pending
April 7, 2026 4:00 PM - StreetInsider
Insmed (INSM) PT Raised to $212 at RBC Capital
April 7, 2026 9:05 AM - StreetInsider
Form 144 INSMED Inc Filed by: Lewis William
April 6, 2026 4:43 PM - SEC Filing
Form 4 INSMED Inc For: Apr 01 Filed by: Adsett Roger
April 3, 2026 4:08 PM - SEC Filing
Form 144 INSMED Inc Filed by: Adsett Roger
April 1, 2026 5:11 PM - SEC Filing
Form ARS INSMED Inc For: Dec 31
April 1, 2026 4:04 PM - SEC Filing
Form DEFA14A INSMED Inc
April 1, 2026 4:03 PM - SEC Filing
Form DEF 14A INSMED Inc For: May 13
April 1, 2026 4:02 PM - SEC Filing
Insmed (INSM) PT Raised to $237 at Barclays
April 1, 2026 6:36 AM - StreetInsider
Form 4 INSMED Inc For: Mar 30 Filed by: Smith Michael Alexander
March 31, 2026 4:13 PM - SEC Filing
Form 144 INSMED Inc Filed by: Smith Michael Alexander
March 30, 2026 5:34 PM - SEC Filing
Stifel on Insmed (INSM): UTHR trial meeting endpoint removes overhang for INSM
March 30, 2026 8:47 AM - StreetInsider
Leerink Partners on Insmed (INSM): competitor data gives positive readthrough, continues re-rate
March 30, 2026 8:43 AM - StreetInsider
Jefferies on Insmed (INSM): UTHR data 'validates inhaled prostacyclin class in IPF,' INSM's TPIP potl BIC
March 30, 2026 8:29 AM - StreetInsider
Morgan Stanley Upgrades Insmed (INSM) to Overweight
March 30, 2026 4:13 AM - StreetInsider
Form SCHEDULE 13G/A INSMED Inc Filed by: VANGUARD GROUP INC
March 27, 2026 9:53 AM - SEC Filing
Insmed (INSM) PT Raised to $245 at H.C. Wainwright
March 26, 2026 11:16 AM - StreetInsider
Insmed (INSM) PT Raised to $206 at Mizuho following positive data
March 24, 2026 8:27 AM - StreetInsider
Insmed (INSM) PT Raised to $208 at Stifel: Arikayce Peak Sales Revised Upwards
March 24, 2026 6:56 AM - StreetInsider
Insmed (INSM) PT Raised to $213 at BofA Securities
March 23, 2026 12:48 PM - StreetInsider
Insmed (INSM) PT Raised to $215 at Leerink Partners
March 23, 2026 12:07 PM - StreetInsider
Insmed (INSM) PT Raised to $203 at RBC Capital
March 23, 2026 12:07 PM - StreetInsider
Insmed shares rise as Arikayce trial data point to larger market opportunity
March 23, 2026 11:05 AM - StreetInsider
Insmed (INSM) PT Raised to $230 at Jefferies
March 23, 2026 10:13 AM - StreetInsider
Wolfe Research on Insmed (INSM): 'expect stock to converge toward PT over next few quarters'
March 23, 2026 9:47 AM - StreetInsider
William Blair on Insmed (INSM): 'data overall supports approval'
March 23, 2026 8:48 AM - StreetInsider
Stifel on Insmed (INSM): Topline data disclosure removes potential NT downside risk
March 23, 2026 8:06 AM - StreetInsider
Form 8-K INSMED Inc For: Mar 23
March 23, 2026 7:01 AM - SEC Filing
Insmed reports successful phase 3b trial for lung disease drug ARIKAYCE
March 23, 2026 7:01 AM - StreetInsider
Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease
March 23, 2026 7:00 AM - PR NewsWire
Insmed (INSM) PT Lowered to $175 at Wells Fargo
March 23, 2026 6:59 AM - StreetInsider
Jefferies says these are the best SMID-cap biotech stocks to buy
March 22, 2026 10:00 AM - StreetInsider
Form 4 INSMED Inc For: Mar 19 Filed by: Lewis William
March 20, 2026 4:06 PM - SEC Filing
Form 144 INSMED Inc Filed by: Lewis William
March 19, 2026 4:57 PM - SEC Filing
Jefferies Starts Insmed (INSM) at Buy
March 16, 2026 9:30 AM - StreetInsider
Full Article List
